<DOC>
	<DOCNO>NCT00611273</DOCNO>
	<brief_summary>Long term efficacy study GFX patient undergo reduction glabellar furrowing</brief_summary>
	<brief_title>A Multi-center Long Term Efficacy Trial GFX For Reduction Glabellar Furrowing</brief_title>
	<detailed_description>A Multi-center Long Term Efficacy Trial GFX Reduction Glabellar Furrowing</detailed_description>
	<criteria>The patient include : Has medical contraindication Presents correction glabellar furrow , classify per Rated Numeric Kinetic Line Scale Score Facial Wrinkles Secondary Hyperkinetic Function ( Class 1 Higher ) Is least 18 year age Signs write informed consent Understands accepts obligation present schedule followup visit Understands GFX procedure may successful Presents one month followup visit improvement base line RNKLS score The patient exclude : Has injection botulinum toxin target area within previous 4 month still exhibit positive cosmetic effect glabellar frown . Has silicone , fat , collagen synthetic material place glabellar region surgical correction excision glabellar furrow Has know bleed disorder Pregnant Has receive anticipate receive antiplatelets , anticoagulant , thrombolytic , cancer therapy Is receive systemic corticosteroid anabolic steroid ( standard dos inhale nasal corticosteroid acceptable ) Has history chronic recurrent infection compromise immune system Has severe allergy manifest history anaphylaxis Has know lidocaine hypersensitivity Is enrol another study Has history keloid formation The investigator believe patient suitable candidate GFX procedure , likely receive cosmetic benefitPresents one month followup visit improvement base line RNKLS score</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Glabellar Furrowing</keyword>
</DOC>